BTG3 and systemic lupus erythematosus: At the manufacturer’s cut-off (120 IU/mL), the sensitivity of AtheNA Multi-Lyte ANA-II for SLE diagnosis was 38.1%, and the specificity was 98.5% (Online Supplementary Table 1, Figure 1).